IL6 and migraine disorder: Specifically, Mt2 appears to integrate endothelial‐derived nitric oxide production (NOS2), cytokine/chemokine release (TNF‐α/IL‐6), and neuropeptide activity (CGRP) to gate vascular tone regulation and neuronal excitability, ultimately driving migraine‐like behavioral manifestations.